Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment
2020-01-01 Lopetuso, L. R.; Corbi, M.; Scaldaferri, F.; Petito, V.; Graziani, C.; Castri, F.; Neri, M.; Gasbarrini, A.; Sgambato, A.; Papa, A.
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature
2020-01-01 Papa, V.; Giustiniani, M. C.; Lopetuso, L. R.; Papa, A.; Papa, V.; Giustiniani, M. C.; Lopetuso, L. R.; Papa, A.
Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota's Crosstalk
2024-01-01 Di Mattia, Miriam; Sallese, Michele; Neri, Matteo; Lopetuso, Loris Riccardo
Coeliac disease under a microscope: Histological diagnostic features and confounding factors
2019-01-01 Gibiino, G.; Lopetuso, L.; Ricci, R.; Gasbarrini, A.; Cammarota, G.
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
2017-01-01 Scaldaferri, F.; D‘ambrosio, D.; Holleran, G.; Poscia, A.; Petito, V.; Lopetuso, L.; Graziani, C.; Laterza, L.; Pistone, M. T.; Pecere, S.; Currò, D.; Gaetani, E.; Armuzzi, A.; Papa, A.; Cammarota, G.; Gasbarrini, A.
Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease
2020-01-01 Lopetuso, L. R.; Gasbarrini, A.
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications
2020-01-01 Scaldaferri, Franco; Ianiro, Gianluca; Privitera, Giuseppe; Lopetuso, Loris Riccardo; Vetrone, Lorenzo Maria; Petito, Valentina; Pugliese, Daniela; Neri, Matteo; Cammarota, Giovanni; Ringel, Yehuda; Costamagna, Guido; Gasbarrini, Antonio; Boskoski, Ivo; Armuzzi, Alessandro
Radiomics could predict surgery at 10 years in Crohn's disease
2023-01-01 Laterza, L.; Boldrini, L.; Tran, H. E.; Votta, C.; Larosa, L.; Minordi, L. M.; Maresca, R.; Pugliese, D.; Zocco, M. A.; Ainora, M. E.; Lopetuso, L. R.; Papa, A.; Armuzzi, A.; Gasbarrini, A.; Scaldaferri, F.
Development and Validation of Predictive Assessment of Complicated Diverticulitis Score
2021-01-01 Covino, M.; Papa, V.; Tursi, A.; Simeoni, B.; Lopetuso, L. R.; Vetrone, L. M.; Franceschi, F.; Rapaccini, G.; Gasbarrini, A.; Papa, A.
Orphan patients with inflammatory bowel disease - when we treat beyond evidence
2021-01-01 Privitera, G.; Pugliese, D.; Lopetuso, L. R.; Scaldaferri, F.; Papa, A.; Rapaccini, G. L.; Gasbarrini, A.; Armuzzi, A.
Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders
2019-01-01 Macchione, I. G.; Lopetuso, L. R.; Ianiro, G.; Napol, M.; Gibiino, G.; Rizzatt, G.; Petito, V.; Gasbarrini, A.; Scaldaferri, F.
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
2022-01-01 Papa, A.; Scaldaferri, F.; Covino, M.; Tursi, A.; Furfaro, F.; Mocci, G.; Lopetuso, L. R.; Maconi, G.; Bibbo, S.; Fiorani, M.; Laterza, L.; Mignini, I.; Napolitano, D.; Parisio, L.; Pizzoferrato, M.; Privitera, G.; Pugliese, D.; Schepis, T.; Schiavoni, E.; Settanni, C. R.; Vetrone, L. M.; Armuzzi, A.; Danese, S.; Gasbarrini, A.
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment
2020-01-01 Ponziani, F. R.; Scaldaferri, F.; De Siena, M.; Mangiola, F.; Matteo, M. V.; Pecere, S.; Petito, V.; Paroni Sterbini, F.; Lopetuso, L. R.; Masucci, L.; Cammarota, G.; Sanguinetti, M.; Gasbarrini, A.
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders
2017-01-01 Lopetuso, L. R.; Petito, V.; Graziani, C.; Schiavoni, E.; Paroni Sterbini, F.; Poscia, A.; Gaetani, E.; Franceschi, F.; Cammarota, G.; Sanguinetti, M.; Masucci, L.; Scaldaferri, F.; Gasbarrini, A.
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
2023-01-01 Lopetuso, L. R.; Cuomo, C.; Mignini, I.; Gasbarrini, A.; Papa, A.
The gastrointestinal microbiome - Functional interference between stomach and intestine
2014-01-01 Lopetuso, L. R.; Scaldaferri, F.; Franceschi, F.; Gasbarrini, A.
Knowledge of Diagnostic and Therapeutic Aspects of IBD among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey
2021-01-01 Napolitano, D.; Scaldaferri, F.; Fiorino, G.; Spagnuolo, R.; Leonetti, A.; Lopetuso, L. R.; Cocchieri, A.
Gut Virome and Inflammatory Bowel Disease
2016-01-01 Lopetuso, L. R.; Ianiro, G.; Scaldaferri, F.; Cammarota, G.; Gasbarrini, A.
Role of microbiota and innate immunity in recurrent clostridium difficile infection
2014-01-01 Bibbò, S.; Lopetuso, L. R.; Ianiro, G.; Di Rienzo, T.; Gasbarrini, A.; Cammarota, G.
Dietary magnesium alleviates experimental murine colitis through upregulation of the transient receptor potential melastatin 6 channel
2018-01-01 Trapani, V.; Petito, V.; Di Agostini, A.; Arduini, D.; Hamersma, W.; Pietropaolo, G.; Luongo, F.; Arena, V.; Stigliano, E.; Lopetuso, L. R.; Gasbarrini, A.; Wolf, F. I.; Scaldaferri, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment | 1-gen-2020 | Lopetuso, L. R.; Corbi, M.; Scaldaferri, F.; Petito, V.; Graziani, C.; Castri, F.; Neri, M.; Gasbarrini, A.; Sgambato, A.; Papa, A. | |
| Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature | 1-gen-2020 | Papa, V.; Giustiniani, M. C.; Lopetuso, L. R.; Papa, A.; Papa, V.; Giustiniani, M. C.; Lopetuso, L. R.; Papa, A. | |
| Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota's Crosstalk | 1-gen-2024 | Di Mattia, Miriam; Sallese, Michele; Neri, Matteo; Lopetuso, Loris Riccardo | |
| Coeliac disease under a microscope: Histological diagnostic features and confounding factors | 1-gen-2019 | Gibiino, G.; Lopetuso, L.; Ricci, R.; Gasbarrini, A.; Cammarota, G. | |
| Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab | 1-gen-2017 | Scaldaferri, F.; D‘ambrosio, D.; Holleran, G.; Poscia, A.; Petito, V.; Lopetuso, L.; Graziani, C.; Laterza, L.; Pistone, M. T.; Pecere, S.; Currò, D.; Gaetani, E.; Armuzzi, A.; Papa, A.; Cammarota, G.; Gasbarrini, A. | |
| Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease | 1-gen-2020 | Lopetuso, L. R.; Gasbarrini, A. | |
| The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications | 1-gen-2020 | Scaldaferri, Franco; Ianiro, Gianluca; Privitera, Giuseppe; Lopetuso, Loris Riccardo; Vetrone, Lorenzo Maria; Petito, Valentina; Pugliese, Daniela; Neri, Matteo; Cammarota, Giovanni; Ringel, Yehuda; Costamagna, Guido; Gasbarrini, Antonio; Boskoski, Ivo; Armuzzi, Alessandro | |
| Radiomics could predict surgery at 10 years in Crohn's disease | 1-gen-2023 | Laterza, L.; Boldrini, L.; Tran, H. E.; Votta, C.; Larosa, L.; Minordi, L. M.; Maresca, R.; Pugliese, D.; Zocco, M. A.; Ainora, M. E.; Lopetuso, L. R.; Papa, A.; Armuzzi, A.; Gasbarrini, A.; Scaldaferri, F. | |
| Development and Validation of Predictive Assessment of Complicated Diverticulitis Score | 1-gen-2021 | Covino, M.; Papa, V.; Tursi, A.; Simeoni, B.; Lopetuso, L. R.; Vetrone, L. M.; Franceschi, F.; Rapaccini, G.; Gasbarrini, A.; Papa, A. | |
| Orphan patients with inflammatory bowel disease - when we treat beyond evidence | 1-gen-2021 | Privitera, G.; Pugliese, D.; Lopetuso, L. R.; Scaldaferri, F.; Papa, A.; Rapaccini, G. L.; Gasbarrini, A.; Armuzzi, A. | |
| Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders | 1-gen-2019 | Macchione, I. G.; Lopetuso, L. R.; Ianiro, G.; Napol, M.; Gibiino, G.; Rizzatt, G.; Petito, V.; Gasbarrini, A.; Scaldaferri, F. | |
| Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study | 1-gen-2022 | Papa, A.; Scaldaferri, F.; Covino, M.; Tursi, A.; Furfaro, F.; Mocci, G.; Lopetuso, L. R.; Maconi, G.; Bibbo, S.; Fiorani, M.; Laterza, L.; Mignini, I.; Napolitano, D.; Parisio, L.; Pizzoferrato, M.; Privitera, G.; Pugliese, D.; Schepis, T.; Schiavoni, E.; Settanni, C. R.; Vetrone, L. M.; Armuzzi, A.; Danese, S.; Gasbarrini, A. | |
| Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment | 1-gen-2020 | Ponziani, F. R.; Scaldaferri, F.; De Siena, M.; Mangiola, F.; Matteo, M. V.; Pecere, S.; Petito, V.; Paroni Sterbini, F.; Lopetuso, L. R.; Masucci, L.; Cammarota, G.; Sanguinetti, M.; Gasbarrini, A. | |
| Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders | 1-gen-2017 | Lopetuso, L. R.; Petito, V.; Graziani, C.; Schiavoni, E.; Paroni Sterbini, F.; Poscia, A.; Gaetani, E.; Franceschi, F.; Cammarota, G.; Sanguinetti, M.; Masucci, L.; Scaldaferri, F.; Gasbarrini, A. | |
| Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases | 1-gen-2023 | Lopetuso, L. R.; Cuomo, C.; Mignini, I.; Gasbarrini, A.; Papa, A. | |
| The gastrointestinal microbiome - Functional interference between stomach and intestine | 1-gen-2014 | Lopetuso, L. R.; Scaldaferri, F.; Franceschi, F.; Gasbarrini, A. | |
| Knowledge of Diagnostic and Therapeutic Aspects of IBD among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey | 1-gen-2021 | Napolitano, D.; Scaldaferri, F.; Fiorino, G.; Spagnuolo, R.; Leonetti, A.; Lopetuso, L. R.; Cocchieri, A. | |
| Gut Virome and Inflammatory Bowel Disease | 1-gen-2016 | Lopetuso, L. R.; Ianiro, G.; Scaldaferri, F.; Cammarota, G.; Gasbarrini, A. | |
| Role of microbiota and innate immunity in recurrent clostridium difficile infection | 1-gen-2014 | Bibbò, S.; Lopetuso, L. R.; Ianiro, G.; Di Rienzo, T.; Gasbarrini, A.; Cammarota, G. | |
| Dietary magnesium alleviates experimental murine colitis through upregulation of the transient receptor potential melastatin 6 channel | 1-gen-2018 | Trapani, V.; Petito, V.; Di Agostini, A.; Arduini, D.; Hamersma, W.; Pietropaolo, G.; Luongo, F.; Arena, V.; Stigliano, E.; Lopetuso, L. R.; Gasbarrini, A.; Wolf, F. I.; Scaldaferri, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista13748
- 3 Libro1
Data di pubblicazione
- In corso di stampa6
- 2020 - 20268039
- 2010 - 20194339
- 2000 - 20091095
- 1990 - 1999225
- 1980 - 198943
- 1979 - 19792
Editore
- Dykinson1
- Luigi Pellegrini Editore1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...265
- JOURNAL OF CLINICAL MEDICINE152
- CANCERS124
- SCIENTIFIC REPORTS119
- JOURNAL OF BIOLOGICAL REGULATORS ...112
- Q-TIMES WEBMAGAZINE111
- PLOS ONE104
- INTERNATIONAL JOURNAL OF ENVIRONM...103
- APPLIED SCIENCES93
- JOURNAL OF ORTHOPAEDIC SURGERY AN...72
Keyword
- Humans372
- COVID-19351
- SARS-CoV-2187
- Male169
- Female160
- Italy110
- Middle Aged103
- Adult90
- Aged87
- inflammation76
Lingua
- eng9929
- ita1581
- fre41
- spa26
- und12
- pol7
- ger5
- por5
- afr1
- enm1
Accesso al fulltext
- no fulltext13743
- reserved6